Talanta, Год журнала: 2025, Номер unknown, С. 128159 - 128159
Опубликована: Апрель 1, 2025
Язык: Английский
Talanta, Год журнала: 2025, Номер unknown, С. 128159 - 128159
Опубликована: Апрель 1, 2025
Язык: Английский
Materials Today Bio, Год журнала: 2025, Номер 32, С. 101663 - 101663
Опубликована: Март 14, 2025
Язык: Английский
Процитировано
0Analytical Science Advances, Год журнала: 2025, Номер 6(1)
Опубликована: Апрель 1, 2025
ABSTRACT Cardiac troponin I (cTnI) is a crucial biological macromolecule found in the contractile apparatus of cardiac myocytes, exclusively expressed cardiomyocytes. It released into bloodstream upon tissue injury, serving as vital biomarker for early detection various heart diseases. Despite advancements cTnI diagnostics and cardiovascular disease (CVD) detection, there an ongoing need more effective diagnostic methods innovative approaches. Current CVD diagnosis often relies on clinical signs symptoms, supplemented by molecular imaging (MI) or biomarkers associated with CVD. However, challenges remain regarding reliability, specificity accuracy analyses myocardial infarction, particularly its stages. Emerging nanomaterial systems present promising solutions enhancing tools due to their unique physical chemical properties. Various nanomaterials, such gold nanoparticles, carbon nanotubes, quantum dots, lipids polymer are paving new pathways detection. The science offer exciting opportunities screening. This article provides comprehensive overview these advancements, categorizing research efforts focused both optical electrochemical platforms, thereby contributing evolution screening methodologies addressing critical reliable solutions.
Язык: Английский
Процитировано
0Talanta, Год журнала: 2025, Номер unknown, С. 128159 - 128159
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0